In Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome
Version 2 2024-06-05, 05:09
Version 1 2023-10-23, 02:33
journal contribution
posted on 2024-06-05, 05:09 authored by M Maes, B Kanchanatawan, S Sirivichayakul, AF CarvalhoIn Schizophrenia, Deficits in Natural IgM Isotype Antibodies Including those Directed to Malondialdehyde and Azelaic Acid Strongly Predict Negative Symptoms, Neurocognitive Impairments, and the Deficit Syndrome
History
Journal
Molecular NeurobiologyVolume
56Pagination
5122-5135Location
Heidelberg, GermanyPublisher DOI
ISSN
0893-7648eISSN
1559-1182Language
engPublication classification
C1 Refereed article in a scholarly journalIssue
7Publisher
SpringerUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC